Quantitative autoradiography of Na+-dependent [3H]L-aspartate binding to L-glutamate transporters in rat brain: Structure-activity studies using L-trans-pyrrolidine-2,4-dicarboxylate (L-t-PDC) and 2-(carboxycyclopropyl)-glycine (CCG)

Neurochemistry International

Volumn 36, Issue 4-5, 2000, Pages 319-327

  Lieb, Inna ^a   Chebib, Mary ^b   Cooper, Benedict ^a   Dias, Leonora S ^a   Balcar, Vladimir J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b University of Sydney   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

1 AMINO 1,3 CYCLOPENTANEDICARBOXYLIC ACID; 1 AMINO 1,5 INDANDICARBOXYLIC ACID; 2 (CARBOXYCYCLOPROPYL)GLYCINE; 2,4 PYRROLIDINEDICARBOXYLIC ACID; 4 PHOSPHONOMETHYLPIPECOLIC ACID; ASPARTIC ACID; DICARBOXYLIC ACID DERIVATIVE; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; GLYCINE DERIVATIVE; SODIUM; TRITIUM;

ANIMAL TISSUE; AUTORADIOGRAPHY; BINDING SITE; BRAIN; CONFERENCE PAPER; CONTROLLED STUDY; DENSITOMETRY; DRUG BINDING; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STRUCTURE ACTIVITY RELATION;

AMINO ACID TRANSPORT SYSTEM X-AG; AMINO ACIDS, DICARBOXYLIC; ANIMALS; ASPARTIC ACID; ATP-BINDING CASSETTE TRANSPORTERS; AUTORADIOGRAPHY; BRAIN; DICARBOXYLIC ACIDS; EXCITATORY AMINO ACID AGONISTS; FEMALE; FREEZING; MALE; NEUROTRANSMITTER UPTAKE INHIBITORS; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; SODIUM; STRUCTURE-ACTIVITY RELATIONSHIP; TRITIUM;

EID: 0033963248     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(99)00140-0     Document Type: Conference Paper

References (57)

1. Amin N., Pearce B. Glutamate toxicity in neuron-enriched and neuron-astrocyte co-cultures: effect of the glutamate uptake inhibitor L-trans-pyrrolidine-2,4-dicarboxylate. Neurochem. Int. 30:1997;271-276.
2. Arriza J.L., Eliasof S., Kavanaugh M., Amara S.G. Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to the chloride conductance. Proc. Natl. Acad Sci. USA. 94:1997;4155-4160.
3. +-dependent high-affinity uptake of L-glutamate in cultured fibroblasts. FEBS Lett. 300:1992;203-207.
4. Balcar V.J., Johnston G.A.R. The structural specificity of the high affinity uptake of L-glutamate and L-aspartate by rat brain slices. J. Neurochem. 19:1972;2657-2666.
5. Balcar V.J., Li Y. Heterogeneity of high affinity uptake of L-glutamate and L-aspartate in the mammalian central nervous system. Life Sci. 51:1992;1467-1478.
6. 3H]kainate studied by autoradiography in rat forebrain. Neurochem. Int. 26:1995;155-164.
7. +-dependent high affinity uptake of L-glutamate in primary cultures of human fibroblasts isolated from three different types of tissue. FEBS Lett. 339:1994;50-54.
8. Berman S.B., Hastings T.G. Inhibition of glutamate transport in synaptosomes by dopamine oxidation and reactive oxygen species. J. Neurochem. 69:1997;1185-1195.
9. Blitzblau R., Gupta S., Djali S., Robinson M.B., Rosenberg P.A. The glutamate transport inhibitor L-trans-pyrrolidine-2,4-dicarboxylate indirectly evokes NMDA receptor mediated neurotoxicity in rat cortical cultures. Eur. J. Neurosci. 8:1996;1840-1852.
10. Bridges R.J., Lovering F.E., Koch H., Cotman C.W., Chamberlin A.R. A conformationally constrained competitive inhibitor of the sodium-dependent transporter in forebrain synaptosomes: L-anti,endo-3,4-methanopyrrolidine dicarboxylate. Neurosci. Lett. 174:1994;193-197.
11. Bristol L.A., Rothstein J.D. Glutamate transporter gene expression in amyotrophic lateral sclerosis motor cortex. Ann. Neurol. 39:1996;676-679.
12. Charalambous B.M., Wheeler K.P. Sodium-induced conformation changes in membrane transport proteins. FEBS Lett. 189:1985;163-166.
13. Cooper B., Chebib M., Shen J., King N.J.C., Darvey I.G., Kuchel P.W., Rothstein J.D., Balcar V.J. Structural selectivity and molecular nature of L-glutamate transport in cultured human fibroblasts. Arch. Biochem. Biophys. 353:1998;356-364.
14. +-dependent binding of D-aspartate in brain membranes is largely due to uptake into membrane-bounded saccules. J. Neurochem. 47:1986;819-824.
15. Dodd P.R., Scott H.L., Westphalen R.I. Excitotoxic mechanisms in the pathogenesis of dementia. Neurochem. Int. 25:1994;203-219.
16. Erecinska M., Silver I.A. Metabolism and role of glutamate in mammalian brain. Prog. Neurobiol. 35:1990;245-296.
17. Fairman W., Vandenberg R.J., Arriza J.L., Kavanaugh M.P., Amara S.G. An excitatory amino acid transporter with properties of ligand-gated chloride channel. Nature. 375:1995;599-603.
18. Fletcher E.J., Johnston G.A.R. Regional heterogeneity of L-glutamate and L-aspartate high affinity uptake systems in the rat CNS. J. Neurochem. 57:1991;911-914.
19. Fletcher E.J., Mewett K.N., Drew C.A., Allan R.D., Johnston G.A.R. Inhibition of high affinity L-glutamic acid uptake into rat cortical synatosomes by the conformationally restricted analogue of glutamic acid, cis-1-aminocyclobutane-1,3-dicarboxylic acid. Neurosci. Lett. 121:1991;133-135.
20. Fonnum F. Glutamate: a neurotransmitter in mammalian brain. J. Neurochem. 42:1984;1-11.
21. Gegelashvili G., Schousboe A. High affinity glutamate transporters: regulation of expression and activity. Mol. Pharmacol. 52:1997;6-15.
22. Gegelashvili G., Schousboe A. Cellular distribution and kinetic properties of high affinity glutamate transporters. Brain Res. Bull. 45:1998;233-238.
23. Gu Z.-Q., Hesson D.P., Pelletier J.C., Maccecchini M.-L. Synthesis, resolution and biological evaluation of the four stereoisomers of 4-methylglutamic acid: selective probes for kainate receptors. J. Med. Chem. 38:1995;2518-2520.
24. +-dependent glutamate uptake in rat hippocampal astrocyte cultures. J. Neurochem. 67:1996;277-286.
25. Ito I., Kohda A., Tanabe S., Hirose E., Hayashi M., Mitsunaga S., Sugiama L. 3,5-Dihydroxyphenylglycine: a potent agonist of metabotropic glutamate receptors. Neuroreport. 3:1992;1013-1016.
26. Keller J.N., Pang Z., Geddes J.W., Begley J.G., Germayer A., Waeg G., Mattson M.P. Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid β-peptide: role of the lipid peroxidation product 4-hydroxynonenal. J. Neurochem. 69:1997;273-284.
27. Killinger S., Li Y., Balcar V.J. Sensitivity of binding sites on glutamate transporters to neurotoxic agents. Neuroreport. 6:1995;1290-1292.
28. Killinger S., Blume G.L., Bohart A., Bested A., Dias L.S., Cooper B., Allan R.D., Balcar V.J. Autoradiographic studies indicate regional variations in the characteristics of L-glutamate transporters in the rat brain. Neurosci. Lett. 216:1996;101-104.
29. Lehman J., Hutchison A.J., McPherson S.E., Mondadori C., Schmutz M., Sinton C.M., Tasi C., Murphy D.E., Steel D.J., Williams M., Cheney D.L., Wood P.L. CGS 19755, a selective and competitive N-methyl-D-aspartate-type excitatory amino acid receptor antagonist. J. Pharmocol. Exp. Ther. 246:1988;65-75.
30. Lehre K.P., Danbolt N.C. The number of glutamate transporter subtype molecules at glutamatergic synapses: chemical and stereological quantification in young adult rat brain. J. Neurosci. 18:1998;8751-8757.
31. Lehre K.P., Levy L.M., Ottersen O.P., Storm-Mathisen J., Danbolt N.C. Differential expression of two glial glutamate transporters in the rat brain: quantitative and immunocytochemical observations. J. Neurosci. 15:1995;1835-1853.
32. 3H]L-aspartate in thaw-mounted sections of rat forebrain. Exp. Brain Res. 97:1994;415-422.
33. Lin C.L., Bristol L.A., Jin L., Dykes-Hoberg M., Crawford T., Clawson L., Rothstein J.D. Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron. 20:1998;589-602.
34. Masliah E., Alford M., DeTeresa R., Mallory M., Hansen L. Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease. Ann. Neurol. 40:1996;759-766.
35. Meaney J.A., Balcar V.J., Rothstein J.D., Jeffrey P.L. Glutamate transport in cultures from developing avian cerebellum: presence of GLT-1 immunoreactivity in Purkinje neurons. J. Neurosci. Res. 54:1998;595-603.
36. Motulsky H.J., Ransnas L.A. Fittings curves to data using non-linear regression: a practical and non-mathematical review. FASEB J. 1:1987;365-374.
37. Munson P.J., Rodbard D. LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Analyt. Biochem. 107:1980;220-239.
38. Nicholls D., Attwell D. The release and uptake of excitatory amino acids. Trends Pharmacol. Sci. 11:1990;462-468.
39. Ong W.Y., Motin L.G., Hansen M.A., Dias L.S., Ayrout C., Bennett M.R., Balcar V.J. P2 Purinoceptor blocker suramin antagonises receptors and protects against excitatory behaviour caused by NMDA receptor agonist (RS)-(tetrazol-5-yl)-glycine in rats. J. Neurosci. Res. 49:1997;627-638.
40. Parpura-Gill A., Beitz D., Uemura E. The inhibitory effect of β-amyloid on glutamate and glucose uptakes by cultured astrocytes. Brain Res. 754:1997;65-71.
41. Pellicciari R., Luneia R., Constantino G., Marinozzi M., Natalini B., Jakobsen P., Kanstrup A., Lombardi G., Moroni F., Thomsen C. 1-Aminoindan-1,5-dicarboxylic acid: a novel antagonist at phospholipase C-linked metabotropic glutamate receptors. J. Med. Chem. 38:1995;3717-3719.
42. Pin J.P., Duvoisin R. Review: neurotransmitter receptors - I: the metabotropic glutamate receptors: structure and functions. Neuropharmacol. 34:1995;1-26.
43. 3H-glutamate transport in synaptosomes. Synapse. 18:1994;21-26.
44. +-dependent glutamate transporters in the mammalian CNS. Adv. Pharmacol. 37:1997;69-115.
45. Rothstein J.D., Jin L., Dykes-Hoberg M., Kuncl R.W. Proc. Natl. Acad. Sci. USA. 90:1993;6591-6595.
46. Rothstein J.D., Van Kammen M., Levey A.I., Martin L.J., Kuncl R.W. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol. 38:1995;73-84.
47. Rothstein J.D., Martin L., Levey A.I., Dykes-Hoberg M., Jin L., Wu D., Nash N., Kuncl R.W. Localization of neuronal and glial glutamate transporters. Neuron. 13:1994;713-725.
48. Rothstein J.D., Dykes-Hoberg M., Pardo C.A., Bristol L.A., Jin L., Kuncl R.W., Kanai Y., Hediger M.A., Wang Y., Schielke J., Welty D.F. Knockout of glutamate transporters reveals a major role for astroglial transport in neurotoxicity and clearance of glutamate. Neuron. 16:1996;675-686.
49. Schoepp D.D., Smith C.G., Lodge D., Miller J.D., Leander J.D., Sacaan A.I., Lunn W.H.W. DL-(Tetrazol-5-yl)-glycine: a novel and highly potent NMDA receptor antagonist. Eur. J. Pharmacol. 203:1991;237-243.
50. Schousboe A., Westergaard N. Pathologic consequences in hippocampus of abberation in the metabolic trafficking between neurons and glial cells necessary for normal glutamate homeostasis. Nitsch R., Ohm T.G. Hippocampus 3. 1993;165-173. (Special issue).
51. Schousboe A., Westergaard N., Sonnewald U., Petersen S.F., Huang R., Peng L., Hertz L. Glutamate and glutamine metabolism and compartmentation in astrocytes. Dev. Neurosci. 15:1993;359-366.
52. Scott H.L., Tannenberg A.E.G., Dodd P.R. Variant forms of neuronal glutamate transporter sites in Alzheimer disease cerebral cortex. J. Neurochem. 64:1995;2193-2202.
53. Tong G., Jahr C.E. Block of glutamate transporters potentiates postsynaptic excitation. Neuron. 13:1994;1195-1203.
54. 3H]α,β-methylene-ATP binding sites in medulla oblongata and spinal cord of the rat. Neurochem. Inter. 30:1997;159-169.
55. Vandenberg R.J., Mitrovic A.D., Chebib M., Balcar V.J., Johnston G.A.R. Contrasting modes of action of methylglutamate derivatives on the excitatory amino acid transporters, EAAT1 and EAAT2. Mol. Pharmacol. 51:1997;809-815.
56. Voltera A., Trotti D., Tromba C., Floridi F., Racagni G. Glutamate uptake inhibition by oxygen free radicals in cortical astrocytes. J. Neurosci. 14:1994;2924-2932.
57. Westergaard N., Sonnewald U., Schousboe A. Metabolic trafficking between neurons and astrocytes: the glutamate-glutamine cycle revisited. Dev. Neurosci. 17:1995;203-211.